nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—Temozolomide—brain cancer	0.131	0.39	CbGbCtD
Trametinib—CYP3A4—Lomustine—brain cancer	0.112	0.332	CbGbCtD
Trametinib—CYP2C8—Etoposide—brain cancer	0.0665	0.198	CbGbCtD
Trametinib—CYP3A4—Etoposide—brain cancer	0.027	0.0802	CbGbCtD
Trametinib—MAP2K1—hindbrain—brain cancer	0.0101	0.123	CbGeAlD
Trametinib—MAP2K1—brainstem—brain cancer	0.00577	0.0702	CbGeAlD
Trametinib—MAP2K1—telencephalon—brain cancer	0.00512	0.0623	CbGeAlD
Trametinib—MAP2K2—telencephalon—brain cancer	0.00451	0.0549	CbGeAlD
Trametinib—MAP2K1—gonad—brain cancer	0.00428	0.052	CbGeAlD
Trametinib—MAP2K2—gonad—brain cancer	0.00376	0.0458	CbGeAlD
Trametinib—MAP2K2—pituitary gland—brain cancer	0.00367	0.0447	CbGeAlD
Trametinib—Mucosal inflammation—Hydroxyurea—brain cancer	0.00365	0.0147	CcSEcCtD
Trametinib—MAP2K1—spinal cord—brain cancer	0.00359	0.0437	CbGeAlD
Trametinib—MAP2K2—medulla oblongata—brain cancer	0.00354	0.0431	CbGeAlD
Trametinib—MAP2K2—midbrain—brain cancer	0.00324	0.0394	CbGeAlD
Trametinib—MAP2K1—endocrine gland—brain cancer	0.00323	0.0393	CbGeAlD
Trametinib—MAP2K1—head—brain cancer	0.00319	0.0388	CbGeAlD
Trametinib—Hypomagnesaemia—Hydroxyurea—brain cancer	0.00318	0.0128	CcSEcCtD
Trametinib—MAP2K2—spinal cord—brain cancer	0.00316	0.0384	CbGeAlD
Trametinib—Lymphopenia—Temozolomide—brain cancer	0.00309	0.0124	CcSEcCtD
Trametinib—Neoplasm malignant—Procarbazine—brain cancer	0.00306	0.0123	CcSEcCtD
Trametinib—Cerebral haemorrhage—Carmustine—brain cancer	0.00295	0.0119	CcSEcCtD
Trametinib—MAP2K1—central nervous system—brain cancer	0.00291	0.0354	CbGeAlD
Trametinib—Cerebral haemorrhage—Temozolomide—brain cancer	0.00285	0.0115	CcSEcCtD
Trametinib—MAP2K1—cerebellum—brain cancer	0.00285	0.0346	CbGeAlD
Trametinib—MAP2K2—endocrine gland—brain cancer	0.00284	0.0346	CbGeAlD
Trametinib—MAP2K2—head—brain cancer	0.00281	0.0342	CbGeAlD
Trametinib—MAP2K2—central nervous system—brain cancer	0.00256	0.0312	CbGeAlD
Trametinib—Melaena—Procarbazine—brain cancer	0.00255	0.0103	CcSEcCtD
Trametinib—MAP2K2—cerebellum—brain cancer	0.00251	0.0305	CbGeAlD
Trametinib—Cyst—Carmustine—brain cancer	0.00245	0.00986	CcSEcCtD
Trametinib—MAP2K1—brain—brain cancer	0.00231	0.0281	CbGeAlD
Trametinib—Mucosal inflammation—Etoposide—brain cancer	0.00228	0.0092	CcSEcCtD
Trametinib—Renal failure—Lomustine—brain cancer	0.00226	0.00912	CcSEcCtD
Trametinib—Stomatitis—Lomustine—brain cancer	0.00224	0.00905	CcSEcCtD
Trametinib—Vaginal haemorrhage—Temozolomide—brain cancer	0.00214	0.0086	CcSEcCtD
Trametinib—Creatinine increased—Hydroxyurea—brain cancer	0.00213	0.00856	CcSEcCtD
Trametinib—Haemoglobin—Lomustine—brain cancer	0.00208	0.00837	CcSEcCtD
Trametinib—Haemorrhage—Lomustine—brain cancer	0.00207	0.00833	CcSEcCtD
Trametinib—MAP2K2—brain—brain cancer	0.00204	0.0248	CbGeAlD
Trametinib—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00192	0.00774	CcSEcCtD
Trametinib—Rash maculo-papular—Hydroxyurea—brain cancer	0.00184	0.00741	CcSEcCtD
Trametinib—Neoplasm—Hydroxyurea—brain cancer	0.00183	0.00737	CcSEcCtD
Trametinib—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00174	0.007	CcSEcCtD
Trametinib—Infection—Carboplatin—brain cancer	0.00167	0.00672	CcSEcCtD
Trametinib—Leukopenia—Lomustine—brain cancer	0.00161	0.00649	CcSEcCtD
Trametinib—Pancreatitis—Procarbazine—brain cancer	0.00161	0.00648	CcSEcCtD
Trametinib—Renal failure acute—Hydroxyurea—brain cancer	0.00159	0.00641	CcSEcCtD
Trametinib—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00158	0.00637	CcSEcCtD
Trametinib—Neoplasm—Carmustine—brain cancer	0.00148	0.00596	CcSEcCtD
Trametinib—Dry eye—Temozolomide—brain cancer	0.00146	0.00588	CcSEcCtD
Trametinib—Infection—Lomustine—brain cancer	0.00146	0.00588	CcSEcCtD
Trametinib—Thrombocytopenia—Lomustine—brain cancer	0.00144	0.00579	CcSEcCtD
Trametinib—Neoplasm—Temozolomide—brain cancer	0.00143	0.00576	CcSEcCtD
Trametinib—Stomatitis—Procarbazine—brain cancer	0.00143	0.00574	CcSEcCtD
Trametinib—Haematuria—Procarbazine—brain cancer	0.00139	0.00562	CcSEcCtD
Trametinib—Cellulitis—Etoposide—brain cancer	0.00139	0.0056	CcSEcCtD
Trametinib—Epistaxis—Procarbazine—brain cancer	0.00138	0.00556	CcSEcCtD
Trametinib—Blood creatinine increased—Hydroxyurea—brain cancer	0.00138	0.00554	CcSEcCtD
Trametinib—Body temperature increased—Carboplatin—brain cancer	0.00133	0.00535	CcSEcCtD
Trametinib—Haemoglobin—Procarbazine—brain cancer	0.00132	0.00532	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00132	0.00531	CcSEcCtD
Trametinib—Haemorrhage—Procarbazine—brain cancer	0.00131	0.00529	CcSEcCtD
Trametinib—Decreased appetite—Lomustine—brain cancer	0.00128	0.00514	CcSEcCtD
Trametinib—CYP2C8—pituitary gland—brain cancer	0.00127	0.0155	CbGeAlD
Trametinib—Phosphatase alkaline increased—Etoposide—brain cancer	0.00126	0.0051	CcSEcCtD
Trametinib—Pancreatitis—Hydroxyurea—brain cancer	0.00124	0.00501	CcSEcCtD
Trametinib—Hyponatraemia—Carmustine—brain cancer	0.00119	0.0048	CcSEcCtD
Trametinib—Neutropenia—Hydroxyurea—brain cancer	0.00119	0.00478	CcSEcCtD
Trametinib—Chills—Procarbazine—brain cancer	0.00118	0.00475	CcSEcCtD
Trametinib—Arrhythmia—Procarbazine—brain cancer	0.00117	0.00472	CcSEcCtD
Trametinib—Body temperature increased—Lomustine—brain cancer	0.00116	0.00468	CcSEcCtD
Trametinib—Rash maculo-papular—Etoposide—brain cancer	0.00115	0.00463	CcSEcCtD
Trametinib—Mouth ulceration—Etoposide—brain cancer	0.00114	0.00461	CcSEcCtD
Trametinib—Infestation—Hydroxyurea—brain cancer	0.00113	0.00456	CcSEcCtD
Trametinib—Infestation NOS—Hydroxyurea—brain cancer	0.00113	0.00456	CcSEcCtD
Trametinib—Stomatitis—Hydroxyurea—brain cancer	0.0011	0.00444	CcSEcCtD
Trametinib—Hypokalaemia—Carmustine—brain cancer	0.00108	0.00435	CcSEcCtD
Trametinib—Dehydration—Temozolomide—brain cancer	0.00107	0.0043	CcSEcCtD
Trametinib—Anaemia—Procarbazine—brain cancer	0.00106	0.00426	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00106	0.00425	CcSEcCtD
Trametinib—Dry skin—Temozolomide—brain cancer	0.00105	0.00424	CcSEcCtD
Trametinib—Hypokalaemia—Temozolomide—brain cancer	0.00104	0.00421	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00103	0.00416	CcSEcCtD
Trametinib—Leukopenia—Procarbazine—brain cancer	0.00102	0.00412	CcSEcCtD
Trametinib—Haemoglobin—Hydroxyurea—brain cancer	0.00102	0.00411	CcSEcCtD
Trametinib—Haemorrhage—Hydroxyurea—brain cancer	0.00102	0.00409	CcSEcCtD
Trametinib—Cardiac failure congestive—Etoposide—brain cancer	0.00101	0.00408	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00101	0.00408	CcSEcCtD
Trametinib—Cough—Procarbazine—brain cancer	0.000997	0.00402	CcSEcCtD
Trametinib—Hypertension—Procarbazine—brain cancer	0.000986	0.00397	CcSEcCtD
Trametinib—CYP2C8—endocrine gland—brain cancer	0.000985	0.012	CbGeAlD
Trametinib—Myalgia—Procarbazine—brain cancer	0.000973	0.00392	CcSEcCtD
Trametinib—Arthralgia—Procarbazine—brain cancer	0.000973	0.00392	CcSEcCtD
Trametinib—Neutropenia—Carmustine—brain cancer	0.000959	0.00387	CcSEcCtD
Trametinib—Dry mouth—Procarbazine—brain cancer	0.000951	0.00383	CcSEcCtD
Trametinib—Vomiting—Lomustine—brain cancer	0.000934	0.00376	CcSEcCtD
Trametinib—Oedema—Procarbazine—brain cancer	0.000933	0.00376	CcSEcCtD
Trametinib—Neutropenia—Temozolomide—brain cancer	0.000927	0.00374	CcSEcCtD
Trametinib—Infection—Procarbazine—brain cancer	0.000926	0.00373	CcSEcCtD
Trametinib—Hyperglycaemia—Carmustine—brain cancer	0.000925	0.00373	CcSEcCtD
Trametinib—Angiopathy—Hydroxyurea—brain cancer	0.000922	0.00371	CcSEcCtD
Trametinib—Thrombocytopenia—Procarbazine—brain cancer	0.000913	0.00368	CcSEcCtD
Trametinib—Chills—Hydroxyurea—brain cancer	0.000911	0.00367	CcSEcCtD
Trametinib—Hyperhidrosis—Procarbazine—brain cancer	0.000901	0.00363	CcSEcCtD
Trametinib—Renal failure—Carmustine—brain cancer	0.000899	0.00362	CcSEcCtD
Trametinib—Hyperglycaemia—Temozolomide—brain cancer	0.000894	0.0036	CcSEcCtD
Trametinib—Stomatitis—Carmustine—brain cancer	0.000892	0.00359	CcSEcCtD
Trametinib—Urinary tract infection—Carmustine—brain cancer	0.000889	0.00358	CcSEcCtD
Trametinib—Erythema—Hydroxyurea—brain cancer	0.000884	0.00356	CcSEcCtD
Trametinib—Infestation—Temozolomide—brain cancer	0.000884	0.00356	CcSEcCtD
Trametinib—Infestation NOS—Temozolomide—brain cancer	0.000884	0.00356	CcSEcCtD
Trametinib—Nausea—Lomustine—brain cancer	0.000872	0.00352	CcSEcCtD
Trametinib—Stomatitis—Temozolomide—brain cancer	0.000862	0.00347	CcSEcCtD
Trametinib—Urinary tract infection—Temozolomide—brain cancer	0.000859	0.00346	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00085	0.00342	CcSEcCtD
Trametinib—Insomnia—Procarbazine—brain cancer	0.000843	0.0034	CcSEcCtD
Trametinib—Haemoglobin—Carmustine—brain cancer	0.000825	0.00333	CcSEcCtD
Trametinib—Haemorrhage—Carmustine—brain cancer	0.000821	0.00331	CcSEcCtD
Trametinib—Anaemia—Hydroxyurea—brain cancer	0.000817	0.00329	CcSEcCtD
Trametinib—Decreased appetite—Procarbazine—brain cancer	0.000811	0.00327	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Etoposide—brain cancer	0.00081	0.00326	CcSEcCtD
Trametinib—Oedema peripheral—Carmustine—brain cancer	0.000809	0.00326	CcSEcCtD
Trametinib—Connective tissue disorder—Carmustine—brain cancer	0.000807	0.00325	CcSEcCtD
Trametinib—Fatigue—Procarbazine—brain cancer	0.000804	0.00324	CcSEcCtD
Trametinib—Haemoglobin—Temozolomide—brain cancer	0.000798	0.00321	CcSEcCtD
Trametinib—Constipation—Procarbazine—brain cancer	0.000797	0.00321	CcSEcCtD
Trametinib—Haemorrhage—Temozolomide—brain cancer	0.000794	0.0032	CcSEcCtD
Trametinib—Leukopenia—Hydroxyurea—brain cancer	0.000792	0.00319	CcSEcCtD
Trametinib—Urinary tract disorder—Temozolomide—brain cancer	0.000784	0.00316	CcSEcCtD
Trametinib—Oedema peripheral—Temozolomide—brain cancer	0.000782	0.00315	CcSEcCtD
Trametinib—Connective tissue disorder—Temozolomide—brain cancer	0.00078	0.00314	CcSEcCtD
Trametinib—Urethral disorder—Temozolomide—brain cancer	0.000778	0.00313	CcSEcCtD
Trametinib—Eye disorder—Carmustine—brain cancer	0.000767	0.00309	CcSEcCtD
Trametinib—Gastrointestinal pain—Procarbazine—brain cancer	0.000763	0.00307	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000748	0.00301	CcSEcCtD
Trametinib—Neutropenia—Etoposide—brain cancer	0.000742	0.00299	CcSEcCtD
Trametinib—Eye disorder—Temozolomide—brain cancer	0.000742	0.00299	CcSEcCtD
Trametinib—Abdominal pain—Procarbazine—brain cancer	0.000737	0.00297	CcSEcCtD
Trametinib—Body temperature increased—Procarbazine—brain cancer	0.000737	0.00297	CcSEcCtD
Trametinib—Cardiac disorder—Temozolomide—brain cancer	0.000737	0.00297	CcSEcCtD
Trametinib—Arrhythmia—Carmustine—brain cancer	0.000734	0.00296	CcSEcCtD
Trametinib—Oedema—Hydroxyurea—brain cancer	0.000722	0.00291	CcSEcCtD
Trametinib—Angiopathy—Temozolomide—brain cancer	0.00072	0.0029	CcSEcCtD
Trametinib—Mental disorder—Carmustine—brain cancer	0.000719	0.0029	CcSEcCtD
Trametinib—Infection—Hydroxyurea—brain cancer	0.000717	0.00289	CcSEcCtD
Trametinib—Mediastinal disorder—Temozolomide—brain cancer	0.000715	0.00288	CcSEcCtD
Trametinib—Erythema—Carmustine—brain cancer	0.000715	0.00288	CcSEcCtD
Trametinib—Malnutrition—Carmustine—brain cancer	0.000715	0.00288	CcSEcCtD
Trametinib—Chills—Temozolomide—brain cancer	0.000712	0.00287	CcSEcCtD
Trametinib—Nervous system disorder—Hydroxyurea—brain cancer	0.000708	0.00285	CcSEcCtD
Trametinib—Infestation NOS—Etoposide—brain cancer	0.000707	0.00285	CcSEcCtD
Trametinib—Infestation—Etoposide—brain cancer	0.000707	0.00285	CcSEcCtD
Trametinib—Thrombocytopenia—Hydroxyurea—brain cancer	0.000707	0.00285	CcSEcCtD
Trametinib—CYP2C8—brain—brain cancer	0.000705	0.00857	CbGeAlD
Trametinib—Skin disorder—Hydroxyurea—brain cancer	0.000701	0.00282	CcSEcCtD
Trametinib—Renal failure—Etoposide—brain cancer	0.000695	0.0028	CcSEcCtD
Trametinib—Mental disorder—Temozolomide—brain cancer	0.000695	0.0028	CcSEcCtD
Trametinib—Back pain—Carmustine—brain cancer	0.000691	0.00279	CcSEcCtD
Trametinib—Erythema—Temozolomide—brain cancer	0.000691	0.00278	CcSEcCtD
Trametinib—Malnutrition—Temozolomide—brain cancer	0.000691	0.00278	CcSEcCtD
Trametinib—Stomatitis—Etoposide—brain cancer	0.00069	0.00278	CcSEcCtD
Trametinib—Dysgeusia—Temozolomide—brain cancer	0.000677	0.00273	CcSEcCtD
Trametinib—Vision blurred—Carmustine—brain cancer	0.000674	0.00271	CcSEcCtD
Trametinib—Asthenia—Procarbazine—brain cancer	0.000669	0.0027	CcSEcCtD
Trametinib—Back pain—Temozolomide—brain cancer	0.000668	0.00269	CcSEcCtD
Trametinib—CYP3A4—endocrine gland—brain cancer	0.000667	0.00812	CbGeAlD
Trametinib—Anaemia—Carmustine—brain cancer	0.000661	0.00266	CcSEcCtD
Trametinib—Pruritus—Procarbazine—brain cancer	0.00066	0.00266	CcSEcCtD
Trametinib—Vision blurred—Temozolomide—brain cancer	0.000651	0.00262	CcSEcCtD
Trametinib—Leukopenia—Carmustine—brain cancer	0.00064	0.00258	CcSEcCtD
Trametinib—Anaemia—Temozolomide—brain cancer	0.000639	0.00257	CcSEcCtD
Trametinib—Diarrhoea—Procarbazine—brain cancer	0.000638	0.00257	CcSEcCtD
Trametinib—Decreased appetite—Hydroxyurea—brain cancer	0.000627	0.00253	CcSEcCtD
Trametinib—Urinary tract disorder—Etoposide—brain cancer	0.000627	0.00253	CcSEcCtD
Trametinib—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000623	0.00251	CcSEcCtD
Trametinib—Urethral disorder—Etoposide—brain cancer	0.000622	0.00251	CcSEcCtD
Trametinib—Fatigue—Hydroxyurea—brain cancer	0.000622	0.00251	CcSEcCtD
Trametinib—Leukopenia—Temozolomide—brain cancer	0.000618	0.00249	CcSEcCtD
Trametinib—Hypertension—Carmustine—brain cancer	0.000617	0.00249	CcSEcCtD
Trametinib—Constipation—Hydroxyurea—brain cancer	0.000617	0.00249	CcSEcCtD
Trametinib—Dizziness—Procarbazine—brain cancer	0.000617	0.00248	CcSEcCtD
Trametinib—Myalgia—Carmustine—brain cancer	0.000609	0.00245	CcSEcCtD
Trametinib—Cough—Temozolomide—brain cancer	0.000603	0.00243	CcSEcCtD
Trametinib—CYP3A4—central nervous system—brain cancer	0.000601	0.00732	CbGeAlD
Trametinib—Hypertension—Temozolomide—brain cancer	0.000596	0.0024	CcSEcCtD
Trametinib—Eye disorder—Etoposide—brain cancer	0.000593	0.00239	CcSEcCtD
Trametinib—Vomiting—Procarbazine—brain cancer	0.000593	0.00239	CcSEcCtD
Trametinib—Cardiac disorder—Etoposide—brain cancer	0.000589	0.00237	CcSEcCtD
Trametinib—Arthralgia—Temozolomide—brain cancer	0.000588	0.00237	CcSEcCtD
Trametinib—Myalgia—Temozolomide—brain cancer	0.000588	0.00237	CcSEcCtD
Trametinib—Rash—Procarbazine—brain cancer	0.000588	0.00237	CcSEcCtD
Trametinib—Dermatitis—Procarbazine—brain cancer	0.000587	0.00237	CcSEcCtD
Trametinib—Headache—Procarbazine—brain cancer	0.000584	0.00235	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000584	0.00235	CcSEcCtD
Trametinib—Oedema—Carmustine—brain cancer	0.000583	0.00235	CcSEcCtD
Trametinib—Infection—Carmustine—brain cancer	0.00058	0.00234	CcSEcCtD
Trametinib—Angiopathy—Etoposide—brain cancer	0.000576	0.00232	CcSEcCtD
Trametinib—Dry mouth—Temozolomide—brain cancer	0.000575	0.00232	CcSEcCtD
Trametinib—Mediastinal disorder—Etoposide—brain cancer	0.000572	0.00231	CcSEcCtD
Trametinib—Thrombocytopenia—Carmustine—brain cancer	0.000571	0.0023	CcSEcCtD
Trametinib—Body temperature increased—Hydroxyurea—brain cancer	0.000571	0.0023	CcSEcCtD
Trametinib—Chills—Etoposide—brain cancer	0.00057	0.0023	CcSEcCtD
Trametinib—Oedema—Temozolomide—brain cancer	0.000564	0.00227	CcSEcCtD
Trametinib—Infection—Temozolomide—brain cancer	0.00056	0.00226	CcSEcCtD
Trametinib—Nausea—Procarbazine—brain cancer	0.000554	0.00223	CcSEcCtD
Trametinib—Nervous system disorder—Temozolomide—brain cancer	0.000553	0.00223	CcSEcCtD
Trametinib—Thrombocytopenia—Temozolomide—brain cancer	0.000552	0.00222	CcSEcCtD
Trametinib—Skin disorder—Temozolomide—brain cancer	0.000548	0.00221	CcSEcCtD
Trametinib—Hyperhidrosis—Temozolomide—brain cancer	0.000545	0.0022	CcSEcCtD
Trametinib—Dysgeusia—Etoposide—brain cancer	0.000541	0.00218	CcSEcCtD
Trametinib—Back pain—Etoposide—brain cancer	0.000535	0.00215	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Carmustine—brain cancer	0.000532	0.00214	CcSEcCtD
Trametinib—Muscle spasms—Etoposide—brain cancer	0.000531	0.00214	CcSEcCtD
Trametinib—Insomnia—Carmustine—brain cancer	0.000528	0.00213	CcSEcCtD
Trametinib—Asthenia—Hydroxyurea—brain cancer	0.000518	0.00209	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000514	0.00207	CcSEcCtD
Trametinib—Anaemia—Etoposide—brain cancer	0.000511	0.00206	CcSEcCtD
Trametinib—Insomnia—Temozolomide—brain cancer	0.00051	0.00205	CcSEcCtD
Trametinib—Decreased appetite—Carmustine—brain cancer	0.000507	0.00204	CcSEcCtD
Trametinib—Gastrointestinal disorder—Carmustine—brain cancer	0.000504	0.00203	CcSEcCtD
Trametinib—Constipation—Carmustine—brain cancer	0.000499	0.00201	CcSEcCtD
Trametinib—Leukopenia—Etoposide—brain cancer	0.000495	0.00199	CcSEcCtD
Trametinib—Diarrhoea—Hydroxyurea—brain cancer	0.000494	0.00199	CcSEcCtD
Trametinib—Decreased appetite—Temozolomide—brain cancer	0.00049	0.00197	CcSEcCtD
Trametinib—Gastrointestinal disorder—Temozolomide—brain cancer	0.000487	0.00196	CcSEcCtD
Trametinib—Fatigue—Temozolomide—brain cancer	0.000486	0.00196	CcSEcCtD
Trametinib—Cough—Etoposide—brain cancer	0.000482	0.00194	CcSEcCtD
Trametinib—Constipation—Temozolomide—brain cancer	0.000482	0.00194	CcSEcCtD
Trametinib—Hypertension—Etoposide—brain cancer	0.000477	0.00192	CcSEcCtD
Trametinib—Dizziness—Hydroxyurea—brain cancer	0.000477	0.00192	CcSEcCtD
Trametinib—Gastrointestinal pain—Carmustine—brain cancer	0.000477	0.00192	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000467	0.00188	CcSEcCtD
Trametinib—Abdominal pain—Carmustine—brain cancer	0.000461	0.00186	CcSEcCtD
Trametinib—Body temperature increased—Carmustine—brain cancer	0.000461	0.00186	CcSEcCtD
Trametinib—Gastrointestinal pain—Temozolomide—brain cancer	0.000461	0.00186	CcSEcCtD
Trametinib—Vomiting—Hydroxyurea—brain cancer	0.000459	0.00185	CcSEcCtD
Trametinib—Rash—Hydroxyurea—brain cancer	0.000455	0.00183	CcSEcCtD
Trametinib—Dermatitis—Hydroxyurea—brain cancer	0.000455	0.00183	CcSEcCtD
Trametinib—Headache—Hydroxyurea—brain cancer	0.000452	0.00182	CcSEcCtD
Trametinib—Infection—Etoposide—brain cancer	0.000448	0.00181	CcSEcCtD
Trametinib—Abdominal pain—Temozolomide—brain cancer	0.000446	0.0018	CcSEcCtD
Trametinib—Body temperature increased—Temozolomide—brain cancer	0.000446	0.0018	CcSEcCtD
Trametinib—Thrombocytopenia—Etoposide—brain cancer	0.000442	0.00178	CcSEcCtD
Trametinib—Skin disorder—Etoposide—brain cancer	0.000438	0.00177	CcSEcCtD
Trametinib—Hyperhidrosis—Etoposide—brain cancer	0.000436	0.00176	CcSEcCtD
Trametinib—Nausea—Hydroxyurea—brain cancer	0.000429	0.00173	CcSEcCtD
Trametinib—Asthenia—Carmustine—brain cancer	0.000419	0.00169	CcSEcCtD
Trametinib—Asthenia—Temozolomide—brain cancer	0.000405	0.00163	CcSEcCtD
Trametinib—Diarrhoea—Carmustine—brain cancer	0.000399	0.00161	CcSEcCtD
Trametinib—Pruritus—Temozolomide—brain cancer	0.000399	0.00161	CcSEcCtD
Trametinib—Decreased appetite—Etoposide—brain cancer	0.000392	0.00158	CcSEcCtD
Trametinib—Gastrointestinal disorder—Etoposide—brain cancer	0.00039	0.00157	CcSEcCtD
Trametinib—Fatigue—Etoposide—brain cancer	0.000389	0.00157	CcSEcCtD
Trametinib—Dizziness—Carmustine—brain cancer	0.000386	0.00155	CcSEcCtD
Trametinib—Constipation—Etoposide—brain cancer	0.000386	0.00155	CcSEcCtD
Trametinib—Diarrhoea—Temozolomide—brain cancer	0.000386	0.00155	CcSEcCtD
Trametinib—Dizziness—Temozolomide—brain cancer	0.000373	0.0015	CcSEcCtD
Trametinib—Vomiting—Carmustine—brain cancer	0.000371	0.00149	CcSEcCtD
Trametinib—Gastrointestinal pain—Etoposide—brain cancer	0.000369	0.00149	CcSEcCtD
Trametinib—Rash—Carmustine—brain cancer	0.000368	0.00148	CcSEcCtD
Trametinib—Dermatitis—Carmustine—brain cancer	0.000368	0.00148	CcSEcCtD
Trametinib—Headache—Carmustine—brain cancer	0.000365	0.00147	CcSEcCtD
Trametinib—Vomiting—Temozolomide—brain cancer	0.000358	0.00144	CcSEcCtD
Trametinib—Abdominal pain—Etoposide—brain cancer	0.000357	0.00144	CcSEcCtD
Trametinib—Body temperature increased—Etoposide—brain cancer	0.000357	0.00144	CcSEcCtD
Trametinib—Rash—Temozolomide—brain cancer	0.000355	0.00143	CcSEcCtD
Trametinib—Dermatitis—Temozolomide—brain cancer	0.000355	0.00143	CcSEcCtD
Trametinib—Headache—Temozolomide—brain cancer	0.000353	0.00142	CcSEcCtD
Trametinib—Nausea—Carmustine—brain cancer	0.000347	0.0014	CcSEcCtD
Trametinib—Nausea—Temozolomide—brain cancer	0.000335	0.00135	CcSEcCtD
Trametinib—Asthenia—Etoposide—brain cancer	0.000324	0.0013	CcSEcCtD
Trametinib—Pruritus—Etoposide—brain cancer	0.000319	0.00129	CcSEcCtD
Trametinib—Diarrhoea—Etoposide—brain cancer	0.000309	0.00124	CcSEcCtD
Trametinib—Dizziness—Etoposide—brain cancer	0.000298	0.0012	CcSEcCtD
Trametinib—Vomiting—Etoposide—brain cancer	0.000287	0.00116	CcSEcCtD
Trametinib—Rash—Etoposide—brain cancer	0.000284	0.00115	CcSEcCtD
Trametinib—Dermatitis—Etoposide—brain cancer	0.000284	0.00115	CcSEcCtD
Trametinib—Headache—Etoposide—brain cancer	0.000283	0.00114	CcSEcCtD
Trametinib—Nausea—Etoposide—brain cancer	0.000268	0.00108	CcSEcCtD
Trametinib—MAP2K2—Innate Immune System—VAV1—brain cancer	0.000144	0.000432	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—EGFR—brain cancer	0.000143	0.000429	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—CCND1—brain cancer	0.000143	0.000428	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—EGFR—brain cancer	0.000142	0.000426	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000142	0.000426	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—CTNNB1—brain cancer	0.000141	0.000424	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HES5—brain cancer	0.000141	0.000423	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000141	0.000422	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—STAT3—brain cancer	0.000141	0.000422	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HES1—brain cancer	0.00014	0.000421	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.00014	0.00042	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—STAT3—brain cancer	0.000139	0.000418	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STRADA—brain cancer	0.000137	0.000411	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—EGFR—brain cancer	0.000137	0.00041	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTCH2—brain cancer	0.000136	0.000409	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—STAT3—brain cancer	0.000136	0.000409	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000136	0.000408	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000136	0.000408	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—EGFR—brain cancer	0.000136	0.000408	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000136	0.000408	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IDH1—brain cancer	0.000136	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—EGFR—brain cancer	0.000135	0.000406	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—MYC—brain cancer	0.000135	0.000405	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—VAV1—brain cancer	0.000135	0.000404	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—EGFR—brain cancer	0.000135	0.000404	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—brain cancer	0.000135	0.000403	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—EGFR—brain cancer	0.000134	0.000402	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—VEGFA—brain cancer	0.000133	0.000399	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—EGFR—brain cancer	0.000132	0.000396	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HES5—brain cancer	0.000132	0.000396	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HES1—brain cancer	0.000131	0.000394	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—STAT3—brain cancer	0.00013	0.000391	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HEY1—brain cancer	0.000129	0.000386	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STRADA—brain cancer	0.000128	0.000385	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—EGFR—brain cancer	0.000128	0.000384	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—STAT3—brain cancer	0.000128	0.000383	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—RELA—brain cancer	0.000127	0.000382	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000127	0.000382	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—EGFR—brain cancer	0.000127	0.000382	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—SHH—brain cancer	0.000127	0.000381	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IDH1—brain cancer	0.000127	0.000381	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000127	0.00038	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—EGFR—brain cancer	0.000127	0.00038	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—EGFR—brain cancer	0.000127	0.00038	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—EGFR—brain cancer	0.000127	0.00038	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—MYC—brain cancer	0.000126	0.000379	CbGpPWpGaD
Trametinib—MAP2K2—Disease—DLL1—brain cancer	0.000126	0.000378	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—EGFR—brain cancer	0.000126	0.000378	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—brain cancer	0.000126	0.000377	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—EGFR—brain cancer	0.000126	0.000377	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—RELA—brain cancer	0.000125	0.000376	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—ERBB2—brain cancer	0.000125	0.000373	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—VEGFA—brain cancer	0.000124	0.000373	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000124	0.000373	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000124	0.000372	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—EGFR—brain cancer	0.000124	0.000372	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—EGFR—brain cancer	0.000124	0.000371	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000123	0.00037	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TRPC6—brain cancer	0.000123	0.000368	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—SMO—brain cancer	0.00012	0.000361	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PTCH1—brain cancer	0.00012	0.000361	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HEY1—brain cancer	0.00012	0.000361	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00012	0.00036	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—EGFR—brain cancer	0.00012	0.000359	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—RELA—brain cancer	0.000119	0.000358	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—SHH—brain cancer	0.000119	0.000357	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—EGFR—brain cancer	0.000119	0.000356	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—EGFR—brain cancer	0.000119	0.000356	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000119	0.000356	CbGpPWpGaD
Trametinib—MAP2K1—Disease—DLL1—brain cancer	0.000118	0.000354	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PDGFRA—brain cancer	0.000118	0.000354	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—EGFR—brain cancer	0.000117	0.000352	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—RELA—brain cancer	0.000117	0.000352	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—ERBB2—brain cancer	0.000116	0.000349	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000116	0.000349	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—EGFR—brain cancer	0.000116	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000116	0.000346	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2—brain cancer	0.000115	0.000344	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TRPC6—brain cancer	0.000115	0.000344	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ABR—brain cancer	0.000114	0.000343	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000114	0.000342	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PTCH1—brain cancer	0.000113	0.000338	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—SMO—brain cancer	0.000113	0.000338	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—ERBB2—brain cancer	0.000113	0.000338	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000112	0.000337	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—EGFR—brain cancer	0.000112	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000112	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—brain cancer	0.000111	0.000333	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GLI2—brain cancer	0.00011	0.000331	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PDGFRA—brain cancer	0.00011	0.000331	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—SKP2—brain cancer	0.00011	0.00033	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CDK4—brain cancer	0.00011	0.00033	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000108	0.000325	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2—brain cancer	0.000107	0.000322	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SHH—brain cancer	0.000107	0.000322	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ENO2—brain cancer	0.000107	0.000322	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ABR—brain cancer	0.000107	0.000321	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—ERBB2—brain cancer	0.000105	0.000316	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000105	0.000315	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GLI1—brain cancer	0.000104	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—brain cancer	0.000104	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IRS2—brain cancer	0.000104	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GLI2—brain cancer	0.000103	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—SKP2—brain cancer	0.000103	0.000309	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CDK4—brain cancer	0.000103	0.000309	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000101	0.000304	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SHH—brain cancer	0.0001	0.000301	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ENO2—brain cancer	0.0001	0.000301	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SUFU—brain cancer	9.84e-05	0.000295	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GLI1—brain cancer	9.72e-05	0.000291	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IRS2—brain cancer	9.69e-05	0.000291	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—STAT3—brain cancer	9.66e-05	0.00029	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GFAP—brain cancer	9.5e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—STAT3—brain cancer	9.5e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.36e-05	0.000281	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SUFU—brain cancer	9.21e-05	0.000276	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—VAV1—brain cancer	9.18e-05	0.000275	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—STAT3—brain cancer	9.04e-05	0.000271	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HEY1—brain cancer	9e-05	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GFAP—brain cancer	8.89e-05	0.000267	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—STAT3—brain cancer	8.88e-05	0.000266	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DLL1—brain cancer	8.83e-05	0.000265	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—VEGFA—brain cancer	8.68e-05	0.00026	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—EGFR—brain cancer	8.63e-05	0.000259	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—VAV1—brain cancer	8.59e-05	0.000258	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HEY1—brain cancer	8.42e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—VAV1—brain cancer	8.39e-05	0.000252	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DLL1—brain cancer	8.26e-05	0.000248	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—VEGFA—brain cancer	8.12e-05	0.000244	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—RELA—brain cancer	8.09e-05	0.000243	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—EGFR—brain cancer	8.07e-05	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—ERBB2—brain cancer	8.04e-05	0.000241	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—VAV1—brain cancer	7.85e-05	0.000235	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—EGFR—brain cancer	7.81e-05	0.000234	CbGpPWpGaD
Trametinib—MAP2K2—Disease—VAV1—brain cancer	7.75e-05	0.000232	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—RELA—brain cancer	7.57e-05	0.000227	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—ERBB2—brain cancer	7.52e-05	0.000226	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SHH—brain cancer	7.51e-05	0.000225	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2C9—brain cancer	7.31e-05	0.000219	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—EGFR—brain cancer	7.31e-05	0.000219	CbGpPWpGaD
Trametinib—MAP2K1—Disease—VAV1—brain cancer	7.25e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TRPC6—brain cancer	7.24e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—RELA—brain cancer	7.15e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTCH1—brain cancer	7.12e-05	0.000213	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SMO—brain cancer	7.12e-05	0.000213	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—ERBB2—brain cancer	7.1e-05	0.000213	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CTNNB1—brain cancer	7.04e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SHH—brain cancer	7.02e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PDGFRA—brain cancer	6.87e-05	0.000206	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TRPC6—brain cancer	6.77e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—RELA—brain cancer	6.69e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HES1—brain cancer	6.66e-05	0.0002	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTCH1—brain cancer	6.66e-05	0.0002	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SMO—brain cancer	6.66e-05	0.0002	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ERBB2—brain cancer	6.64e-05	0.000199	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CTNNB1—brain cancer	6.58e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PDGFRA—brain cancer	6.43e-05	0.000193	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PDGFRA—brain cancer	6.34e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HES1—brain cancer	6.23e-05	0.000187	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—BSG—brain cancer	6.22e-05	0.000187	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CTNNB1—brain cancer	6.21e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—brain cancer	6.19e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—STAT3—brain cancer	6.13e-05	0.000184	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IRS2—brain cancer	6.03e-05	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PDGFRA—brain cancer	5.93e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CG—brain cancer	5.83e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CTNNB1—brain cancer	5.81e-05	0.000174	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—brain cancer	5.79e-05	0.000174	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—STAT3—brain cancer	5.74e-05	0.000172	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH2—brain cancer	5.69e-05	0.000171	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IRS2—brain cancer	5.64e-05	0.000169	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EGFR—brain cancer	5.57e-05	0.000167	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IRS2—brain cancer	5.57e-05	0.000167	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CG—brain cancer	5.45e-05	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VAV1—brain cancer	5.42e-05	0.000163	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—IDH1—brain cancer	5.35e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH2—brain cancer	5.32e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EGFR—brain cancer	5.21e-05	0.000156	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IRS2—brain cancer	5.21e-05	0.000156	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VAV1—brain cancer	5.07e-05	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EGFR—brain cancer	4.92e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APC—brain cancer	4.92e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HES1—brain cancer	4.67e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EGFR—brain cancer	4.61e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APC—brain cancer	4.6e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDGFRA—brain cancer	4.44e-05	0.000133	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HES1—brain cancer	4.36e-05	0.000131	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.35e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SPP1—brain cancer	4.31e-05	0.000129	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ENO2—brain cancer	4.23e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—brain cancer	4.16e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDGFRA—brain cancer	4.16e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB2—brain cancer	4.14e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—brain cancer	4.1e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SPP1—brain cancer	4.03e-05	0.000121	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C9—brain cancer	3.93e-05	0.000118	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS2—brain cancer	3.9e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—brain cancer	3.89e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB2—brain cancer	3.87e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—brain cancer	3.84e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB2—brain cancer	3.82e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—brain cancer	3.75e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS2—brain cancer	3.65e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTNNB1—brain cancer	3.62e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB2—brain cancer	3.57e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—brain cancer	3.51e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APC—brain cancer	3.44e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CG—brain cancer	3.44e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTNNB1—brain cancer	3.39e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CTNNB1—brain cancer	3.34e-05	0.0001	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—BSG—brain cancer	3.34e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APC—brain cancer	3.22e-05	9.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CG—brain cancer	3.22e-05	9.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT3—brain cancer	3.15e-05	9.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—brain cancer	3.14e-05	9.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CTNNB1—brain cancer	3.13e-05	9.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT3—brain cancer	2.95e-05	8.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—brain cancer	2.94e-05	8.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—STAT3—brain cancer	2.91e-05	8.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—IDH1—brain cancer	2.87e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—brain cancer	2.87e-05	8.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—STAT3—brain cancer	2.72e-05	8.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—brain cancer	2.71e-05	8.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—brain cancer	2.69e-05	8.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—brain cancer	2.68e-05	8.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB2—brain cancer	2.67e-05	8.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—brain cancer	2.65e-05	7.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—brain cancer	2.53e-05	7.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—brain cancer	2.52e-05	7.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB2—brain cancer	2.5e-05	7.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—brain cancer	2.48e-05	7.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—brain cancer	2.42e-05	7.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCND1—brain cancer	2.36e-05	7.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CTNNB1—brain cancer	2.34e-05	7.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ENO2—brain cancer	2.27e-05	6.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—brain cancer	2.27e-05	6.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCND1—brain cancer	2.21e-05	6.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CTNNB1—brain cancer	2.19e-05	6.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—brain cancer	2.06e-05	6.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT3—brain cancer	2.04e-05	6.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CG—brain cancer	1.94e-05	5.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—brain cancer	1.93e-05	5.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT3—brain cancer	1.91e-05	5.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—brain cancer	1.9e-05	5.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—brain cancer	1.85e-05	5.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—brain cancer	1.77e-05	5.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—brain cancer	1.73e-05	5.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—brain cancer	1.56e-05	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—brain cancer	1.46e-05	4.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CG—brain cancer	1.04e-05	3.12e-05	CbGpPWpGaD
